In the atorvastatin group of MIRACL , short-term risk increased across tertiles of baseline triglycerides ( p = @ ) , with a hazard ratio of @ -LSB- corrected -RSB- ( @ % confidence interval : @ to @ ) in highest/lowest tertiles ( > @/@ mg/dl ) .